App-Quantinova.ai

False positive metanephrines secondary to sinemet-diagnostic dilemmas in interpretation

Bhavna Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Multiple system atrophy

Carbidopa and Levodopa

Monitoring for the long-term metabolic complications in patients with subclinical cushing’s syndrome: service evaluation

Jessica Yau - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cushing's syndrome

Dexamethasone

Adverse events associated with supraphysiological glucocorticoid dosing in congenital adrenal hyperplasia (CAH): results of a structured literature review

Vijay Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital adrenal hyperplasia

Glucocorticoid

Adrenal insufficiency presenting as hypercalcemia and acute kidney injury

Nauman Jadoon - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Primary hyperparathyroidism

Hydrocortisone

The primary aldosteronism rollercoaster: hypoaldosteronism as a potential postoperative complication

August Palma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Fludrocortisone

Managing Immune checkpoint inhibitors and adrenal insufficiency in acute setting

Mahamud Bashir - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Lung Cancer

Hydrocortisone

The burden of illness associated with adolescent and adult congenital adrenal hyperplasia: results of a structured literature review

Uzmah Sabar - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital adrenal hyperplasia

N/A

Serum cortisol immunoassay performance in the overnight dexamethasone suppression test.

Jonathan Atkins - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Dexamethasone

The Adrenal that inCYSTS on causing pain

Christopher Horne - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Lymphangioma

Opiate

Altered steroid metabolism in patients following severe trauma: the golden hour study

Conor Bentley - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

Glucocorticoid

Autosomal dominant hypocalcaemia type 1 with intact PTH and relative hypocalciuria.

Razan Ali Rashid - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Urinary tract infections

Ergocalciferol

Clinical outcomes of COVID-19 infection in rare bone and mineral disorders

Ana Luisa Priego Zurita - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary hyperparathyroidism

N/A

Hypercalcemia in sarcoidosis unmasked by treatment with Vitamin D

Helmine Kejem - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Hypercalcaemia

cholecalciferol

Palovarotene for the treatment of fibrodysplasia ossificans progressiva: methodology of the phase III open-label PIVOINE rollover trial

Alexander Artyomenko - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Fibrodysplasia ossificans progressiva

Palovarotene

Impact of COVID-19 pandemic on waiting time from referral to definitive surgery in primary hyperparathyroidism: a large tertiary centre experience

Razan Ali Rashid - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Primary hyperparathyroidism

N/A

Artificial intelligence technology for the early diagnosis of osteoporosis in cushing syndrome

Margaret McBride - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Cushing's syndrome

Glucocorticoid

Regional Migratory Osteoporosis- An under-diagnosed entity

Ashutosh Kapoor - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Multiple Myeloma

Zolendronic acid

Hypercalcaemia induced acute pancreatitis

Mona Abouzaid - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Gastroesophageal reflux disease

Parathyroid hormone

A pathological fracture of the femur and multiple pelvic osteolytic lesions mimicking bone metastases as the first presentation of Primary Hyperparathyroidism

Haris Khan - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Primary hyperparathyroidism

Alfacalcidol

Osteitis fibrosa cystica as index presentation of severe vitamin D deficiency

Mohammad Jeeyavudeen - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Secondary hyperparathyroidism

Ergocalciferol

Filters

45280 Abstracts